Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2003
05/01/2003US20030082701 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082699 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082698 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082697 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082696 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082695 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082694 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082693 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082692 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082691 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082690 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082689 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082687 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082686 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082685 Chemotherapeutic induction of egr-1 promoter activity
05/01/2003US20030082684 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
05/01/2003US20030082683 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases
05/01/2003US20030082681 Nucleic acids, proteins, and antibodies
05/01/2003US20030082674 Genetically engineered receptor protein for use in the treatment of respiratory system disorders
05/01/2003US20030082673 Homologous recombination expression vector for use as tool in the expression of recombinant genes in rodent cells
05/01/2003US20030082672 Dna encoding galanin galr2 receptors and uses thereof
05/01/2003US20030082649 6299, a human zinc carboxypeptidase family member and uses therefor
05/01/2003US20030082645 Nervous system agent for use in the treatment of psychological disorders
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082642 Transgenic mammalian cells for use diagnostic tool in monitoring cell activities
05/01/2003US20030082641 A method of treating depression using a galr3 receptor antagonist
05/01/2003US20030082636 Antibody for use as tool in the treatment of blood disorders
05/01/2003US20030082634 Novel cell regulation factor TTO 20
05/01/2003US20030082628 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer and nervous system disorders
05/01/2003US20030082627 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082626 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082619 Contiguous and partially overlapping cDNA sequences and polypeptides
05/01/2003US20030082612 Detection of mutant leptin receptor; obtain cells, extract nucleotide sequences, incubate with an oligonucleotide probe, detect hybridization, presence of hybridization, indicates defective receptor
05/01/2003US20030082603 Colon cancer marker
05/01/2003US20030082591 Methods for gene disruption and uses thereof
05/01/2003US20030082575 Translation system for use in the generation of protein containing adjusted amino acid sequences
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082542 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082541 Nucleotide sequences coding polypeptide for use in the treatment of skin disorders and cancer
05/01/2003US20030082540 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082532 Tumor necrosis factor receptor related gene 12 polypeptides
05/01/2003US20030082518 Genetic engineering; quantitative analysis; medical diagnosis
05/01/2003US20030082515 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator
05/01/2003US20030082202 Tryparedoxin, expression plasmid, process of production, method of use, test kit, and pharmaceutical composition
05/01/2003US20030082199 Compositions and methods for the treatment of immune related diseases
05/01/2003US20030082198 Administering complex of heat shock protein and antigen
05/01/2003US20030082197 Administering complex of heat shock protein and antigen
05/01/2003US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases
05/01/2003US20030082182 Antiinflammatory agents, inflammatory bowel disorders, antiulcer agents
05/01/2003US20030082178 Administering chimera protein
05/01/2003US20030082176 Therapy for metabolism disorders
05/01/2003US20030082173 Screening drugs that block lymphocytes; genetic engineered rodent
05/01/2003US20030082172 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
05/01/2003US20030082166 Compounds and methods for modulating nonclassical cadherin-mediated functions
05/01/2003US20030082163 Fused cells, methods of forming same, and therapies utilizing same
05/01/2003US20030082160 Differentiation of whole bone marrow
05/01/2003US20030082158 Production of transduced hematopoietic progenitor cells
05/01/2003US20030082155 Antidiabetic agents; cell differentiation of stem cells
05/01/2003US20030082153 Stem cells that transform to beating cardiomyocytes
05/01/2003US20030082152 Animal growth regulators; controlling cell differentiation; tissue engineering
05/01/2003US20030082148 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo
05/01/2003US20030082144 A viral nucleic acid construct for the high level expression of a heterologous protein in an insect cell; using baculovirus expression vector system for exogenous proteins production
05/01/2003US20030082139 Genetically modified human embryonic cells using a viral vector encoding an oncogene, can express active cytokines, chemokines, and other cytotoxic and neurotoxic substances; used for screening of compounds for diseases
05/01/2003CA2842429A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2793019A1 Humanized antibodies
05/01/2003CA2675409A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2498591A1 Immunotherapy for reversing immune suppression
05/01/2003CA2464695A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003CA2464460A1 In vitro micro-organs, and uses related thereto
05/01/2003CA2464417A1 Promoters to control cell differentiation
05/01/2003CA2464372A1 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003CA2464349A1 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464239A1 Psma antibodies and protein multimers
05/01/2003CA2464088A1 Stem cells that transform to beating cardiomyocytes
05/01/2003CA2463960A1 Transient immortalization
05/01/2003CA2463772A1 Thrombin-cleavable chimeric proteins
05/01/2003CA2463467A1 Cell separation matrix
05/01/2003CA2462712A1 Pig mast cell cultures and uses thereof
05/01/2003CA2462238A1 Specimen vial sealing apparatus and method
05/01/2003CA2461665A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2461543A1 Sperm factor sequences
05/01/2003CA2460665A1 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications
05/01/2003CA2454361A1 Humanized antibodies
04/2003
04/30/2003CN1415019A Method for making insulin precursors and insulin precursor analogus having improved fermentation yield in yeast
04/30/2003CN1415017A UDP-glucose: aglycon-glacosyltransferase
04/30/2003CN1415016A Trichoderma reesei木聚糖酶 Trichoderma reesei xylanase
04/30/2003CN1415013A BASB059 polypeptides from neisseria meningitidis
04/30/2003CN1414974A Method for making insulin precursors and insulin precursor analogs
04/30/2003CN1414973A Insecticidal proteins from bacillus thuringiensis
04/30/2003CN1414865A 癌症的治疗 Treatment of cancer
04/30/2003CN1414102A Binding region of erythrocyte binding protein of Plasmodium vivax and Plasmodium falciform
04/30/2003CN1414018A Binding region of erythrocyte binding protein of plasmodium vivax and plasmodium falciform
04/30/2003CN1107072C Programing cell death induced molecule II
04/30/2003CN1106861C Preparation method of nanometer phase calcium-phosphorus salt/collagen/polylactic acid bone composite material
04/30/2003CN1106846C Antitumor agent
04/29/2003US6555734 Modified dihydroflavonol 4-reductase (DFR) nucleic acids;encoding the modified DFR characterized by its ability to reduce dihydrokaempferol preferentially and increase the content of pelargonidin-based pigments
04/29/2003US6555672 Growth differentiation factor promoter and uses therefor
04/29/2003US6555669 Nucleotide sequences coding preferential oligopeptide for use in human therapeutics and diagnostics; for use in the treatment of cancer and Parkinson's Disease
1 ... 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 ... 1827